AGM and Topic Day Lessons learned from Life Sciences –

Information

Date:

June 20, 2019

Location: VBO-FEB in Brussels (Belgium), Rue Ravesteinstraat 4, Brussels
Description:

Lessons learned from Life Sciences – relevant for all sectors

LES Benelux cordially invites you to this Topic Day on the 20th of June, 2019 in Brussels.

Industry speakers from companies like GSK, J&J, UCB, Celyad, LFB and Imec will share their first-hand experiences. Our acknowledged speakers will discuss the following topics:

  • Competition law issues in the Life Sciences sector – Understand the most pressing current issues of competition law for IP and tech transfer specialists active in the sector of Life Sciences
  • Supplementary Protection Certificates & manufacturing waiver – Master the latest developments in drug life cycle management. Hear an update on SPC case law. Experts from the EU regulator, the industry and law firms will exchange views on the new EU regulation and its impact on the industry.
  • Trade secret protection – What does “reasonable steps” really mean for life sciences companies – Reasonable steps” are required under the EU directive for information to enjoy trade secret protection. What steps are required? What does it mean in practice.
  • The business of buying/selling technology – How do Life Sciences BD people actually work? How do they identify the technologies and deals of interest? How do they approach negotiation? Experience sharing from different (industry, VC and university) angles.
  • Compensation for employee invention – How do companies deal with employee invention? Including in the framework of clinical trials (patents based on results)? And including in the USA? First-hand practical experience from industry experts.
  • Successful R&D set-ups – Innovation centers and incubators. How do they work? How can I get in? Real life experience sharing

 

DETAILS

DATE
Thursday 20 June 2019 from 10.00 till 17.00

VENUE
VBO-FEB, Rue Ravensteinstraat 4, Brussels, Belgium. See www.vbo-feb.be for a map and directions.

FEE
The special fee for this AGM and meeting will be € 90,00 for LES members. For LES members 40 years of age or below there is a discount of € 20,00 under the condition of completing your date of birth at the online registration form.

The fee is € 180,00 for non-members. Please note that for non-members from one of the Benelux countries the fee also includes membership of LES Benelux for 2019.

Members who wish to attend only the half hour AGM are welcome at no charge. Members of LES are entitled to vote at the AGM. Non-members are most welcome to attend as observers but have no right to vote.

Participation includes meeting materials, buffet lunch, coffee and tea in the break and drinks after the meeting.

Payment can take place by bank transfer or by credit card. Your registration will be confirmed with an invoice for the registration fee.

 

REGISTRATION
Members and non-members are kindly requested to register online via the online registration form

EDUCATIONAL POINTS
The program contains 5 substantive hours (5 educational points). Please contact the Registration Desk on the day of the meeting for the necessary lists to sign. A certificate of attendance will be sent by email after the meeting.

PARTICIPANTS
Please note that this topic meeting is open for LES members and non-members worldwide. However, from participants it is expected that they have at least an academic background (law, financial or technical).

PROGRAM AND PRESENTATIONS
The speakers at this meeting will be kindly requested to make their presentations available for publication at the LES Benelux website. All participants will receive instructions by e-mail how to access these presentations.

Programme

09.30  Registration and welcome coffee

10.00  Welcome and introduction, William (Bill) Bird, President of LES Benelux

10.05  Competition law issues in the Life Sciences sector.

Understand the most pressing current issues of competition law for IP and tech transfer specialists active in the sector of Life Sciences

Maarten Meulenbelt, Sidley, Partner will be interviewed by Jean-Christophe Troussel, chairman of the topic day.

10.40  Supplementary Protection Certificates & manufacturing waiver. 

Master the latest developments in drug life cycle management. Hear an update on SPC case law. Experts from the EU regulator, the industry and law firms will exchange views on the new EU regulation and its impact on the industry

A panel discussion by Frank Landolt, Confo Therapeutics, Elise Melon and UCB, Denis Dambois, European Commission, DG GROW, Unit F3. Moderated by Claudia Zeri, Barents Krans.

 12.00  Annual General Meeting

12.30  Lunch

13.30  Trade secret protection – What does “reasonable steps” really mean for life sciences companies

Reasonable steps” are required under the EU directive for information to enjoy trade secret protection. What steps are required? What does it mean in practice for life sciences companies, incl. biotech companies

Presented by Bart Goddyn, Celyad and Domien Op de Beeck, Bird & Bird

14.00  The business of buying/selling technology

How do Life Sciences BD people actually work? How do they identify the technologies and deals of interest? How do they approach negotiation? Experience sharing from different (industry, VC and university) angles.

Presented by Emmanuel Lacroix, UCB Ventures, Frits Fallaux, Leiden University and Julian Bouchard, GSK.

15.10  Compensation for employee invention

How do companies deal with employee invention? Including in the framework of clinical trials (patents based on results)? And including in the USA? First-hand practical experience from industry experts.

Presented by Laurence Le Texier, LFB Group and Kevin Nachtrab, Johnson & Johnson, Senior Patent Attorney

15.55  Networking tea/coffee break

16.15  Successful R&D set-ups

 Innovation centers and incubators. How do they work? How can I get in? Real life experience sharing

Presented by Elke Giets, YESSE Technologies, Vincent Ryckaert, IMEC and Frank Bulens, partner imec.xpand Fund

          Moderated by Laura MacDonald, ASTP

17.15  Closing words by the chairman of the day

17.20  Networking drinks

Speakers

Julian Bouchard
GSK, Head Vaccine Business Development
Frank Bulens
IMEC, partner imec.xpand Fund
Denis Dambois
European Commission, DG GROW, Unit F3 – Intellectual Property and Fight Against Counterfeiting, Legal and policy officer
Frits Fallaux
LURIS, Leiden University, Senior Business Developer Commercial Impact Team
Elke Giets
Yesse Technologies, Managing Director
Bart Goddyn
Celyad, Legal Director
Emmanuel Lacroix
UCB Ventures, Partner
Frank Landolt
Confo Therapeutics, Chief Counsel IP & Legal
Laurence Le Texier
LFB Group, Head of Patent Litigation
Elise Melon
UCB, Assoc. Director, IP Policy Patent Operations Lead
Maarten Meulenbelt
Sidley, Partner
Kevin Nachtrab
Johnson & Johnson, Senior Patent Attorney
Domien Op de Beeck
Bird & Bird, Counsel
Vincent Ryckaert
IMEC, IP Manager
Jean-Christophe Troussel
Bird & Bird, Partner and chairman of the day
Claudia Zeri
Barents Krans, Senior Associate
Laura MacDonald
ASTP
Members exclusive content

Log in to download presentations.

Login